Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Net Income (2020 - 2025)

Sight Sciences has reported Net Income over the past 6 years, most recently at -$4.2 million for Q4 2025.

  • Quarterly results put Net Income at -$4.2 million for Q4 2025, up 64.87% from a year ago — trailing twelve months through Dec 2025 was -$38.4 million (up 25.4% YoY), and the annual figure for FY2025 was -$38.4 million, up 25.4%.
  • Net Income for Q4 2025 was -$4.2 million at Sight Sciences, up from -$8.2 million in the prior quarter.
  • Over the last five years, Net Income for SGHT hit a ceiling of -$4.2 million in Q4 2025 and a floor of -$23.8 million in Q2 2022.
  • Median Net Income over the past 5 years was -$14.5 million (2023), compared with a mean of -$14.7 million.
  • Biggest five-year swings in Net Income: crashed 112.04% in 2021 and later soared 64.87% in 2025.
  • Sight Sciences' Net Income stood at -$15.9 million in 2021, then dropped by 6.09% to -$16.9 million in 2022, then skyrocketed by 36.77% to -$10.7 million in 2023, then dropped by 10.8% to -$11.8 million in 2024, then soared by 64.87% to -$4.2 million in 2025.
  • The last three reported values for Net Income were -$4.2 million (Q4 2025), -$8.2 million (Q3 2025), and -$11.9 million (Q2 2025) per Business Quant data.